A Study of Remimazolam Tosilate for Sedation in the ICU
Clinical trial NCT05152303 · COMPLETED
Trial details
- NCT number
- NCT05152303
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2023-04-02
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.